Triangle Hi-Fi has expanded its wireless lineup with the CAPELLA 2, the successor to the original CAPELLA powered speakers. Designed and built in France, the CAPELLA 2 continues the brand’s use of ...

Dive into the world of superior sound quality as we unbox the Corsair SP2500 High-Power 2.1 PC Speaker System. Explore every component of this powerful audio setup meticulously designed for ...

HONOLULU (KHON2) — The second phase of Skyline has taken two years and three months, and it’s finally ready to open, with many expecting big changes to their commute. Skyline stations transform into ...

The novel serotonin norepinephrine reuptake inhibitor (SNRI) ammoxetine may effectively treat major depressive disorder (MDD) while avoiding some side effects common to other antidepressants, new ...

SPRINGFIELD, Mo. — A new chapter in south Springfield’s transportation officially begins Friday with the opening of Phase II of the Kansas Expressway Extension. The final phase of the project will ...

Anker has opened up pre-orders for the Soundcore Nebula X1 Pro home theater system after teasing the product at IFA. This is being done via the crowdfunding platform Kickstarter and prices start at $3 ...

A new development in Rochester, known as The Ridge phase 2, is planned to include housing, commercial buildings, and a hospital emergency department. Developers are seeking a permit recommendation ...

We are now witnessing the start of what might be seen as Phase 2 of Trump’s efforts to eradicate political opposition. Phase 1 has centered on silencing criticism. It has featured retribution toward ...

There aren't a ton of boom-or-bust options at quarterback, but that just is who Fields is. We saw him boom last week and explode against the Pittsburgh Steelers. He ended up throwing for 218 yards, ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Summer may be nearing it’s end, but that doesn’t ...

Rapport Therapeutics, Inc.'s RAP-219 delivered impressive Phase 2a results in drug-resistant focal onset seizures, driving Rapport Therapeutics' stock up over 135% and boosting investor optimism. The ...